Evidence-based treatment with methotrexate in children with rheumatic disorders. Consensus statement of the Working Group for Children and Adolescents with Rheumatic Diseases in Germany and the Working Group on Pediatric Rheumatology in Austria;Evidenzbasierter einsatz von methotrexat bei kindern mit rheumatischen erkrankungen. Konsensusstatement der Arbeitsgemeinschaft Kinder- und Jugendrheumatologie Deutschland (AGKJR) und Arbeitsgemeinschaft Pädiatrische Rheumatologie Österreich

Monatsschrift fur Kinderheilkunde

Volumn 151, Issue 8, 2003, Pages 881-890

  Niehues, T ^a   Horneff, G ^b   Michels, H ^b   Sailer Hock M ^b   Schuchmann, L ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b NONE

Author keywords

Children; Evidence based recommendations; Juvenile idiopathic arthritis; Methotrexate

Indexed keywords

ANTIEMETIC AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; BARBITURIC ACID DERIVATIVE; CELECOXIB; CHLOROQUINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN A; DIMENHYDRINATE; ETANERCEPT; FOLIC ACID ANTAGONIST; METHOTREXATE; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; ONDANSETRON; ORAL CONTRACEPTIVE AGENT; PENICILLIN G; PHENYTOIN; PROBENECID; ROFECOXIB; SALAZOSULFAPYRIDINE; TETRACYCLINE; TRANQUILIZER; TROPISETRON;

AUSTRIA; BLOOD TOXICITY; CLINICAL TRIAL; CONFERENCE PAPER; DRUG APPROVAL; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG SAFETY; EVIDENCE BASED MEDICINE; GASTROINTESTINAL SYMPTOM; GERMANY; HODGKIN DISEASE; HUMAN; LIVER TOXICITY; LUNG TOXICITY; MACROPHAGE ACTIVATION; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SOCIETY; NONHODGKIN LYMPHOMA; PANCYTOPENIA; PEDIATRICS; PHYSIOTHERAPY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SIDE EFFECT; TERATOGENICITY; VOMITING;

EID: 0041878483     PISSN: 00269298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00112-003-0737-7     Document Type: Conference Paper

References (84)

1. Aherne GW, Piall E, Marks V, Mould G, White WF (1978) Prolongation and enhancement of serum methotrexate concentrations by probenecid. BMJ 29: 1097-1099
2. Albertioni F, Flato B, Seideman P, Beck O, Vinje O, Peterson C, Eksborg S (1995) Methotrexate in juvenile rheumatoid arthritis. Evidence of age dependent pharmacokinetics. Eur J Clin Pharmacol 47: 507-511
3. Andersen PA, West SG, O'Dell JR, Via CS, Claypool RG, Kotzin BL (1985) Weekly pulse methotrexate in rheumatoid arthritis. Clinical and Immunologic effects in a randomized, double-blind study. Ann Intern Med 103: 489-496
4. Balis FM, Mirro J Jr, Reaman GH, Evans WE, McCully C, Doherty KM, Murphy RF, Jeffries S, Poplack DG (1988) Pharmacokinetics of subcutaneous methotrexate. J Clin Oncol 6: 1882-1886
5. Balis FM, Savitch JL, Bleyer WA (1983) Pharmacokinetics of oral methotrexate in children. Cancer Res 43: 2342-2345
6. Barrera P, Haagsma CJ, Boerbooms AM, Van Riel PL, Borm GF, Van de Putte LB, Van der Meer JW (1995) Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis. Br J Rheumatol 34: 747-755
7. Bawle EV, Conard JV, Weiss L (1998) Adult and two children with fetal methotrexate syndrome. Teratology 57: 51-55
8. Blackburn WD Jr, Alarcon GS (1989) Impotence in three rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 32: 1341-1342
9. Breit W, Frosch M, Meyer U, Heinecke A, Ganser G (2000) A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis. J Rheumatol 27: 2696-2702
10. Brik R, Berkowitz D, Berant M (1998) Duration of methotrexate treatment until partial and total remission of refractory juvenile rheumatoid arthritis. Ann Rheum Dis 57: 174-175
11. Buckley LM, Bullaboy CA, Leichtman L, Marquez M (1997) Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum 40: 971-973
12. Camiciottoli G, Trapani S, Castellani W, Ginanni R, Ermini M, Falcini F (1998) Effect on lung function of methotrexate and non-steroid anti-inflammatory drugs in children with juvenile rheumatoid arthritis. Rheumatol Int 18: 11-16
13. Cassidy JT (1999) Medical management of children with juvenile rheumatoid arthritis. Drugs 58: 837-850
14. Cassidy JT, Petty R (2001) Textbook of pediatric rheumatology, 4th edn. Saunders, Philadelphia
15. Cleary AG, McDowell H, Sills JA (2002) Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma. Arch Dis Child 86: 47-49
16. Cron RQ, Sherry DD, Wallace CA (1998) Methotrexate-induced hypersensitivity pneumonitis in a child with juvenile rheumatoid arthritis. J Pediatr 132: 901-902
17. Cutolo M, Sulli A, Pizzorni C, Seriolo B, Straub RH (2001) Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. Ann Rheum Dis 60: 729-735
18. Dupuis LL, Koren G, Shore A, Silverman ED, Laxer RM (1990) Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis. J Rheumatol 17: 1469-1473
19. Erickson AR, Reddy V, Vogelgesang SA, West SG (1995) Usefulness of the American College of Rheumatology recommendations for liver biopsy in methotrexate-treated rheumatoid arthritis patients, Arthritis Rheum 38: 1115-1119
20. Feldmann W (2000) Evidence-based pediatrics, 1st edn. Decker, Hamilton
21. Franke J, Hafner R, Lohrs U, Truckenbrodt H (1996) Methotrexate and liver fibrosis in juvenile chronic arthritis retrospective study of 73 liver biopsies. Monatsschr Kinderheilkd 144: 147-151
22. Furst DE, Kremer JM (1988) Methotrexate in rheumatoid arthritis. Arthritis Rheum 31: 305-314
23. Giannini EH, Brewer EJ, Kuzmina N, Shaikov A, Maximov A, Vorontsov I, Fink CW, Newman AJ, Cassidy JT, Zemel LS (1992) Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N Engl J Med 326: 1043-1049
24. Gottlieb BS, Keenan GF, Lu T, Ilowite NT (1997) Discontinuation of methotrexate treatment in juvenile rheumatoid arthritis. Pediatrics 100: 994-997
25. Graham LD, Myones BL, Rivas-Chacon RF, Pachman LM (1992) Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis. J Pediatr 120: 468-473
26. Grennan DM, Gray J, Loudon J, Fear S (2001) Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 60: 214-217
27. Hashkes PJ, Balistreri WF, Bove KE, Ballard ET, Passo MH (1997) The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis. Arthritis Rheum 40: 2226-2234
28. Horneff G, Forster J, Seyberth HW, Michels H (2000) Recommendations by the Pediatric and Adolescent Rheumatology Study Committee on therapy with etanercept (p75 TNF-alpha receptor immunoglobulin fusion protein. Pharmacotherapy Committee). Z Rheumatol 59: 365-369
29. Huang JL (1996) Methotrexate in the treatment of children with chronic arthritis - long-term observations of efficacy and safety. Br J Clin Pract 50: 311-314
30. Hunt PG, Rose CD, McIlvain-Simpson G, Tejani S (1997) The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study. J Rheumatol 24: 2230-2232
31. Jundt JW, Browne BA, Fiocco GP, Steele AD, Mock D (1993) A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing. J Rheumatol 20: 1845-1849
32. Kozlowski RD, Steinbrunner JV, MacKenzie AH, Clough JD, Wilke WS, Segal AM (1990) Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 88: 589-592
33. Kremer JM, Galivan J, Streckfuss A, Kamen B (1986) Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum 29: 832-835
34. Kremer JM, Alarcon GS, Lightfoot RW Jr, Willkens RF, Furst DE, Williams HJ, Dent PB, Weinblatt ME (1994) Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum 37: 316-328
35. Kremer JM, Alarcon GS, Weinblatt ME, Kaymakcian MV, Macaluso M, Cannon GW, Palmer WR, Sundy JS, St Clair EW, Alexander RW, Smith GJ, Axiotis CA (1997) Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review. Arthritis Rheum 40: 1829-1837
36. Krugmann J, Sailer-Hock M, Muller T, Gruber J, Allerberger F, Offner FA (2000) Epstein-Barr virus-associated Hodgkin's lymphoma and Legionella pneumophila infection complicating treatment of juvenile rheumatoid arthritis with methotrexate and cyclosporine A. Hum Pathol 31: 253-255
37. Lafforgue P, Monjanel-Mouterde S, Durand A, Catalin J, Acquaviva PC (1993) Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients. J Rheumatol 20: 263-267
38. Londino AV Jr, Blatt J, Knisely AS (1998) Hodgkin's disease in a patient with juvenile rheumatoid arthritis taking weekly low dose methotrexate. J Rheumatol 25: 1245-1246
39. Mariette X, Cazals-Hatem D, Warszawki J, Liote F, Balandraud N, Sibilia J (2002) Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood 1: 3909-3915
40. McKendry RJ (1997) The remarkable spectrum of methotrexate toxicities. Rheum Dis Clin North Am 23: 939-954
41. Morgan SL, Baggott JE, Lee JY, Alarcon GS (1998) Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention. J Rheumatol 25: 441-446
42. Munro R, Porter DR, Sturrock RD (1998) Lymphadenopathy in a patient with systemic onset juvenile chronic arthritis. Ann Rheum Dis 57: 513-517
43. O'Dell JR (1997) Methotrexate use in rheumatoid arthritis. Rheum Dis Clin North Am 23: 779-796
44. O'Dell JR (2001) Combinations of conventional disease-modifying antirheumatic drugs. Rheum Dis Clin North Am 27: 415-426
45. Oguey D, Kolliker F, Gerber NJ, Reichen J (1992) Effect of food on the bioavailability of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 35: 611-614
46. Olsen NJ, Murray LM (1989) Antiproliferative effects of methotrexate on peripheral blood mononuclear cells. Arthritis Rheum 32: 378-385
47. Onel KB (2000) Advances in the medical treatment of juvenile rheumatoid arthritis. Curr Opin Pediatr 12: 72-75
48. Ortiz Z, Shea B, Suarez-Almazor ME, Moher D, Wells GA, Tugwell P (1998) The efficacy of folic acid and folinic acid in reducing methotrexate gastrointestinal toxicity in rheumatoid arthritis. A metaanalysis of randomized controlled trials. J Rheumatol 25: 36-43
49. Padeh S, Passwell JH (1998) Intraarticular corticosteroid injection in the management of children with chronic arthritis. Arthritis Rheum 41: 1210-1214
50. Padeh S, Sharon N, Schiby G, Rechavi G, Passwell JH (1997) Hodgkin's lymphoma in systemic onset juvenile rheumatoid arthritis after treatment with low dose methotrexate. J Rheumatol 24: 2035-2037
51. Pelucchi A, Lomater C, Gerloni V, Foresi A, Fantini F, Marazzini L (1994) Lung function and diffusing capacity for carbon monoxide in patients with juvenile chronic arthritis: effect of disease activity and low dose methotrexate therapy. Clin Exp Rheumatol 12: 675-679
52. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, Maldonado-Cocco J, Suarez-Almazor M, Orozco-Alcala J, Prieur AM (1998) Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 25: 1991-1994
53. Prahalad S, Bove KE, Dickens D, Lovell DJ, Grom AA (2001) Etanercept in the treatment of macrophage activation syndrome. J Rheumatol 28: 2120-2124
54. Rau R (1994) Treatment of chronic polyarthritis with methotrexate 1994 - a review. Z Rheumatol 53: 199-229
55. Ravelli A, Martini A (2000) Methotrexate in juvenile idiopathic arthritis: answers and questions. J Rheumatol 27: 1830-1833
56. Ravelli A, Viola S, Ramenghi B, Aramini L, Ruperto N, Martini A (1995) Frequency of relapse after discontinuation of methotrexate therapy for clinical remission in juvenile rheumatoid arthritis. J Rheumatol 22: 1574-1576
57. Ravelli A, Viola S, Migliavacca D, Ruperto N, Pistorio A, Martini A (1999) The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis. J Pediatr 135: 316-320
58. Ravelli A, Caria MC, Buratti S, Malattia C, Temporini F, Martini A (2001) Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol 28: 865-867
59. th edn. American Academy of Pediatrics, Elk Grove Village, IL, pp 50-58
60. Reiff A, Shaham B, Wood BP, Bernstein BH, Stanley P, Szer IS (1995) High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis. Clin Exp Rheumatol 13: 113-118
61. Reiff A, Rawlings DJ, Shaham B, Franke E, Richardson L, Szer IS, Bernstein BH (1997) Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis. J Rheumatol 24: 2436-2443
62. Rosenblatt DS, Whitehead VM, Vera N, Pottier A, Dupont M, Vuchich MJ (1978) Prolonged inhibition of DNA synthesis associated with the accumulation of methotrexate polyglutamates by cultured human cells. Mol Pharmacol 14: 1143-1147
63. Ruperto N, Murray KJ, Gerloni Wulffraat N, De Oliveira S, Falcinin F, Alessio M, Burgos-Vargas R, Corona F, Vesely R, Foster H, Davidson J, Zulian F, Asplin L, Baildam E, Dolezalova P, Walsh J, Buoncompagni A, Garcia-Consuegra J, Ozdogan H, Saurenmann R, Joos R, Calvo I, Alpigiani LP, Machado C, Lahdenne P, Cortis E, Lepore L, Hall A, Kimura Y, Wouters C, Woo P, Martini A (2002) A randomized trial of methotrexate in medium versus higher doses in children with juvenile idiopathic arthritis who failed on standard dose. EULAR Meeting Stockholm Abstract Nr. 1384
64. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS (1996) Evidence based medicine: what it is and what it isn't. BMJ 13: 71-72
65. Salaffi F, Manganelli P, Carotti M, Subiaco S, Lamanna G, Cervini C (1997) Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature. Clin Rheumatol 16: 296-304
66. Schmeling H, Mathony K, John V, Keysser G, Burdach S, Horneff G (2001) A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study. Ann Rheum Dis 60: 410-412
67. Schmeling H, Stephan V, Burdach S, Horneff G (2002) Pulmonary function in children with juvenile idiopathic arthritis and effects of methotrexate therapy. Z Rheumatol 61: 168-172
68. Seeliger S, Niehues T, Harms E, Frosch M, Roth J (2002) Methotrexat in der Behandlung der juvenilen idiopathischen Arthritis. Monatsschr Kinderheilkd 150: 452-459
69. Seitz M, Loetscher P, Dewald B, Towbin H, Rordorf C, Gallati H, Baggiolini M, Gerber NJ (1995) Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells. Br J Rheumatol 34: 602-609
70. Singsen BH, Goldbach-Mansky R (1997) Methotrexate in the treatment of juvenile rheumatoid arthritis and other pediatric rheumatoid and nonrheumatic disorders. Rheum Dis Clin North Am 23: 811-840
71. Sussman A, Leonard JM (1980) Psoriasis, methotrexate, and oligospermia. Arch Dermatol 116: 215-217
72. Takken T, Van Der Net J, Helders PJ (2001) Methotrexate for treating juvenile idiopathic arthritis. Cochrane Database Syst Rev CD003129
73. Thompson RN, Watts C, Edelman J, Esdaile J, Russell AS (1984) A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. J Rheumatol 11: 760-763
74. Truckenbrodt H, Hafner R (1986) Methotrexate therapy in juvenile rheumatoid arthritis: a retrospective study. Arthritis Rheum 29: 801-807
75. Van Ede AE, Laan RF, Rood MJ, Huizinga TW, Van de Laar MA, Van Denderen CJ, Westgeest TA, Romme TC, De Rooij DJ, Jacobs MJ, De Boo TM, Van der Wilt GJ, Severens JL, Hartman M, Krabbe PF, Dijkmans BA, Breedveld FC, Van de Putte LB (2001) Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 44: 1515-1524
76. Van Ede AE, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM, De Boo TM, Van de Putte LB (2002) Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis. Rheumatology 41: 658-665
77. Wahn V, Oppermann J, Huppertz HI, Zepp F (2001) Rheumatische Erkrankungen ira Kindes- und Jugendalter, 1. Aufl. Hans Marseille, München
78. Wallace CA (1998) The use of methotrexate in childhood rheumatic diseases. Arthritis Rheum 41: 381-391
79. Wallace CA, Bleyer WA, Sherry DD, Salmonson KL, Wedgwood RJ (1989) Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis. Arthritis Rheum 32: 677-681
80. Wallace CA, Smith AL, Sherry DD (1993) Pilot investigation of naproxen/methotrexate interaction in patients with juvenile rheumatoid arthritis. J Rheumatol 20: 1764-1768
81. Weinblatt ME, Coblyn JS, Fox DA, Fraser PA, Holdsworth DE, Glass DN, Trentham DE (1985) Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 312: 818-822
82. Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ (1999) A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340: 253-259
83. Williams HJ, Willkens RF, Samuelson CO Jr et al. (1985) Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 28: 721-730
84. Woo P, Southwood TR, Prieur AM, Dore CJ, Grainger J, David J, Ryder C, Hasson N, Hall A, Lemelle I (2000) Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 43: 1849-1857